Because treatment of the whole prostate can lead to long-term side effects in patients with prostate cancer, interest in ...
Credit: Getty Images The 2024 US Prostate Cancer Conference published 34 consensus recommendations addressing 5 main topic areas. Guidelines created by a multi-disciplinary panel of specialists focus ...
The study's testing accurately identified prostate cancer 91% of the time and accurately ruled out men without prostate cancer 84% of the time. A urine-based biomarker panel may be a promising, ...
AI is becoming crucial in prostate cancer care, improving diagnosis and treatment stratification through enhanced imaging and risk assessment. AI-generated cancer mapping has shown superior accuracy ...
Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, ...
Many men with aggressive prostate cancer can experience a high rate of recurrence despite treatment. A new Phase 2 clinical trial at UC Davis Comprehensive Cancer Center unveiled clues as to why these ...
The significant reliance on forward-looking statements may create uncertainty about the company's future, as actual outcomes could differ materially from expectations due to various risks and ...
Data from a major U.S. clinical trial from the Alliance for Clinical Trials in Oncology has uncovered a genetic factor that may inform how to optimize the dosing of abiraterone, a widely used hormone ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results